ARTICLE | Product Development
21st century pandemic, prehistoric clinical trials: Guest Commentary
It’s long past time to embrace randomized controlled trials as the fastest path to answers in a pandemic, says Luciana Borio
June 26, 2020 6:26 PM UTC
The U.S. is trying to fight a 21st century pandemic with prehistoric clinical trials -- and achieving the kind of efficiency you might expect.
In the last six months, tens of thousand of patients have been enrolled in thousands of clinical trials all over the world, yet these studies have produced actionable answers on only three agents: remdesivir, dexamethasone and hydroxychloroquine. ...